logo-loader

Research

Research update: Health

Tiziana Life Sciences: Advancing at speed

Tiziana (TILS), also listed on NASDAQ (Symbol TLSA), is driving forwards the clinical development plan for...

Emma Ulker

11.39 Wed 05 Aug 2020

technology
Research update: Tech
Location Sciences: Reassuring trading update
1 week, 6 days ago
Primary Health Properties PLC - Primary Health Properties reports strong first half with increase in net rental income and profit
Analyst interview: Finance
Primary Health Properties reports strong first half with increase...
1 week, 3 days ago
Wheaton Precious Metals -
Research: Mining
Dramatic uplift in market interest in royalty companies
2 weeks, 6 days ago
1594809372_Pharmaceutical-biotechnology-medicine-production-lab-science.jpg
Research update: Health
MaxCyte: Firing on all cylinders
3 weeks, 4 days ago
Show all Research news

Meet the real story
Proactive Investors One2One Investor Forum

Initiation Reports

big data Pelatro: Big Data, big growth drivers
1 week, 6 days ago
Health

Tiziana Life Sciences: Transformational potential

Tiziana Life Sciences lead programme Foralumab is notable in that not only is this the only...

3 weeks, 2 days ago
Energy

TomCo Energy: Oil sands project moving forward

TomCo (LON:TOM) is an oil & gas exploration and production company which, operates in the...

on 9/7/20
Health

Revive Therapeutics: Initiation report

Revive Therapeutics (CSE:RVV, OTCQB:RVVTF) is a speciality life sciences company focussed on...

on 30/6/20
Health

Eco Equity - Growing ambition

Eco Equity has established a unique position within the fast-growing market for legal cannabis....

on 12/6/20
Meet the analyst

Trained as a geologist, he has worked on exploration, development and production projects with companies including Barrick Gold, Anglo American and Xstrata in a variety of jurisdictions. He has a PhD in Economic Geology from James Cook University, MSc in Mining Geology...
Introducing the analyst: Ryan Long
Meet the analyst

Prior to founding Hallgarten & Company in 2003, Christopher was the head of research at an economic thinktank in New Jersey. He was also founder and head of research at the esteemed Argentine equity research firm, Buenos Aires Trust Company. 

Christopher Ecclestone
Meet the analyst

Ed has a master’s degree in Mathematics from Oxford and has used his mathematical skills to excel as a support services analyst at HSBC and Societe Generale.

HSBC -
Meet the analyst

Emma has over 15 years’ experience as an equity analyst, mainly across the biotech, pharma and med-tech sectors, including more than 10 years as an analyst at Edison Group where she covered a range of pan-European mid-cap stocks.

Meet the analyst: Emma Ulker
Meet the analyst

Zac has in excess of 25 years’ experience in oil and gas and finance, working for companies such as BP, Chevron, Merrill Lynch and ING Barings, where he undertook finance or finance related roles. 

Meet the analyst: Zac Phillips

Updates

science Tiziana Life Sciences: Advancing at speed
4 days, 2 hours ago
Finance

Primary Health Properties: Steady progress, encouraging prospects

Primary Health Properties (LON:PHP) recently announced interim results for the period to June...

1 week, 3 days ago
Tech

Location Sciences: Reassuring trading update

Location Sciences (LON:LSAI), the world leader in location verification for mobile advertising,...

1 week, 6 days ago
Health

MaxCyte: Firing on all cylinders

MXCT made outstanding progress in H1 20 across the business and is set to report revenue growth...

3 weeks, 4 days ago
Health

MaxCyte: A win in gene silencing with APEIRON Biologics

MaxCyte’s new clinical and commercial licence agreement with Apeiron Biologics allows the...

on 8/7/20

Analyst interviews

Tiziana Life Sciences PLC - Tiziana Life Sciences PLC's clinical plan is shaping up says analyst Emma Ulker

Tiziana Life Sciences PLC's clinical plan is shaping up says analyst Emma Ulker

Proactive Research analyst Emma Ulker says Tiziana Life Sciences PLC (LON:TILS)(NASDAQ:TLSA) is driving forwards at speed with the clinical development plan for its fully-human mAb TZLS-501 COVID-19 treatment. She adds that with GMP-grade manufacturing already underway they've appointed a number...

4 days ago
Primary Health Properties PLC - Primary Health Properties reports strong first half with increase in net rental income and profit Finance Primary Health Properties reports strong first half with increase...
1 week, 3 days ago
Pelatro PLC - Pelatro PLC: Analyst expects growth and profitability to continue in 2020 Tech Pelatro PLC: Analyst expects growth and profitability to continue...
1 week, 6 days ago
Tiziana Life Sciences PLC - Tiziana Life Sciences has potential to 'revolutionise treatment in monoclonal antibodies market' Health Tiziana Life Sciences has potential to 'revolutionise treatment in...
2 weeks, 6 days ago
MaxCyte Inc - MaxCyte Inc 'demonstrating outstanding progress' as first half revenues climb 30% Health MaxCyte Inc 'demonstrating outstanding progress' as first half...
3 weeks, 4 days ago